Bottom line
What is UCPSX's expense ratio?
UCPSX's expense ratio is 2.78%, or about $278 a year on every $10,000 invested. That is more expensive than 99% of leveraged & inverse funds we track (median 1.31%). Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Nov 25, 2025
UCPSX fee table
| Net expense ratio | 2.78% |
|---|---|
| Gross expense ratio | 3.64% |
| Management fee | 0.75% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 1.89% |
| Fee waiver / reimbursement | -0.86% |
Source: Fund prospectus fee table, filed Nov 25, 2025
What UCPSX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| UCPSX | $281 | $1,035 | $1,810 | $3,842 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.78% expense ratio costs roughly $132,200 in lost growth, versus about $70,600 for the median leveraged & inverse fund (1.31%).